Sex and prior exposure jointly shape innate immune responses to a live herpesvirus vaccine
eLife · 17.01.2023 · 12
DOI: 10.7554/elife.80652 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift eLife, online erschienen am 17.01.2023. Verfasst von Foo Cheung und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Human Immunology, National Institutes of Health, Bethesda, United States. Hauptthemen laut MEDLINE: Herpesvirus Vaccines, Immunity, Innate, Sex Factors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Division of Intramural Research, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Background
Both sex and prior exposure to pathogens are known to influence responses to immune challenges, but their combined effects are not well established in humans, particularly in early innate responses critical for shaping subsequent outcomes.
Methods
We employed systems immunology approaches to study responses to a replication-defective, herpes simplex virus (HSV) 2 vaccine in men and women either naive or previously exposed to HSV.
Results
Blood transcriptomic and cell population profiling showed substantial changes on day 1 after vaccination, but the responses depended on sex and whether the vaccinee was naive or previously exposed to HSV. The magnitude of early transcriptional responses was greatest in HSV naive women where type I interferon (IFN) signatures were prominent and associated negatively with vaccine-induced neutralizing antibody titers, suggesting that a strong early antiviral response reduced the uptake of this replication-defective virus vaccine. While HSV seronegative vaccine recipients had upregulation of gene sets in type I IFN (IFN-α/β) responses, HSV2 seropositive vaccine recipients tended to have responses focused more on type II IFN (IFN-γ) genes.
Conclusions
These results together show that prior exposure and sex interact to shape early innate responses that then impact subsequent adaptive immune phenotypes. Funding: Intramural Research Program of the NIH, the National Institute of Allergy and Infectious Diseases, and other institutes supporting the Trans-NIH Center for Human Immunology, Autoimmunity, and Inflammation. The vaccine trial was supported through a clinical trial agreement between the National Institute of Allergy and Infectious Diseases and Sanofi Pasteur. Clinical trial number: NCT01915212.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Human Immunology, National Institutes of Health, Bethesda, United States.
- Medical Virology Section, Laboratory of Infectious Diseases, National Institutes of Health, Bethesda, United States.
- Multiscale Systems Biology Section, Laboratory of Immune System Biology, National Institutes of Health, Bethesda, United States.
ORCID-Profile: Richard Apps, Julian Candia, Harlan Pietz, John S Tsang, Jeffrey I Cohen
Förderung
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Zitieren
APA
Cheung, F., Apps, R., Dropulic, L., Kotliarov, Y., Chen, J., Jordan, T., Langweiler, M., Candia, J., Biancotto, A., Han, K. L., Rachmaninoff, N., Pietz, H., Wang, K., Tsang, J. S., & Cohen, J. I. (2023). Sex and prior exposure jointly shape innate immune responses to a live herpesvirus vaccine. eLife, 12. https://doi.org/10.7554/elife.80652
Vancouver
Cheung F, Apps R, Dropulic L, Kotliarov Y, Chen J, Jordan T, et al. Sex and prior exposure jointly shape innate immune responses to a live herpesvirus vaccine. eLife. 2023;12. doi:10.7554/elife.80652
BibTeX
@article{Cheung2023,
author = {Cheung, Foo and Apps, Richard and Dropulic, Lesia and Kotliarov, Yuri and Chen, Jinguo and Jordan, Tristan and Langweiler, Marc and Candia, Julian and Biancotto, Angelique and Han, Kyu Lee and Rachmaninoff, Nicholas and Pietz, Harlan and Wang, Kening and Tsang, John S and Cohen, Jeffrey I},
title = {Sex and prior exposure jointly shape innate immune responses to a live herpesvirus vaccine},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.80652}
}
EUVIMED